- Registration is now open to view the European HIV Clinical Forum on demand.
- To stay updated on the latest developments, make sure you are signed up for our newsletter.
Meeting category
Date(s)
7 Jun 2022
Program Language
English
Location
Paris,
France
Meeting type
Hybrid Meeting
CME credits
5
Organizer
European HIV Clinical Forum 2022
Related Enduring Materials
Enduring Materials
Session 1 | Antiretroviral Therapy 2022 - State of ART Plenary Lectures - 09:10
Caroline Sabin, PhD
09:10 CEST
International and European Guidelines - Similarities and Differences
Medical Statistics and Epidemiology, University College London (UCL), United Kingdom
09:35 CEST
Resistance Considerations in Choice of Regimen
10:00 CEST
Pharmacological Considerations in Choice of Regimen
10:25 CEST
Comorbidity and Toxicity Considerations in Choice of Regimen
Session 2 | Starting and Switching Antiretroviral Therapy in 2022 - 11:30
11:30 CEST
Considerations in Switching to Newer Regimens in Patients Suppressed on Older Drugs
11:55 CEST
Clinical Case (Focused on Starting and Switching Therapy)
Session 3 | HIV Prevention in 2022 - 13:45
13:45 CEST
Update on Therapeutic Options for HIV Prevention
14:10 CEST
How to Choose Between Oral and IM PrEP for Each Individual
14:35 CEST
Clinical Case (Focused on Prevention)
Session 4 | Optimal Care of Highly Treatment Experienced Patients - Now and in the Future - 15:30
Anna Maria Geretti, MD, PhD, FRCPath
Josep Llibre, MD, PhD
15:30 CEST
Current and Evolving Therapeutic Options for Highly Treatment Experienced Patients
15:55 CEST
Integrating Multiple Novel Agents for Optimal Care of Multiclass Resistant Patients
University of Rome, Italy / King's College London, United Kingdom
16:10 CEST
Clinical Case (Focused on Highly Treatment Experienced Patients)
Fundació Lluita contra la Sida; Hospital Universitari Germans Trias i Pujol, Spain
Overview
Image
What's New
The European HIV Clinical Forum 2022 provided an independent scientific program involving world-leading experts and was specifically designed for European HIV healthcare professionals and focuses on optimizing treatment for their patients.
This program featured challenging plenary lectures followed by ample time for Q&A and debate, stimulating interaction, and the sharing of knowledge within the HIV-treating community in Europe. The program included virtual networking opportunities for community building; thus, providing delegates with the unique opportunity to meet their colleagues in a focused and scientific setting.
The HIV Clinical Forum is a series of interactive programs that provide an independent scientific program on emerging topics in HIV, involving experts where HIV clinicians and allied healthcare professionals receive updates on the latest developments related to HIV management, where they can share their clinical experience, and present results from their ongoing and completed cohorts/ research programs.
Furthermore, the HIV Clinical Forum provides an educational setting where healthcare professionals can acquire specific skills that will enhance their capabilities to interpret research results and even develop new research projects.
Program Director
Local Chair
General Information
Who Should Attend?
Primary: Medical doctors involved in the management and treatment of people living with HIV in the region.
Secondary: Researchers.
Tertiary: Healthcare workers, clinical virologists, microbiologists, scientists, pharmacologists, nurses, post-doctoral researchers, students, and other healthcare professionals involved in treating people living with HIV.
Secondary: Researchers.
Tertiary: Healthcare workers, clinical virologists, microbiologists, scientists, pharmacologists, nurses, post-doctoral researchers, students, and other healthcare professionals involved in treating people living with HIV.
Meeting Objectives
With the HIV Clinical Forum program we aim to:
- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients
- Create a platform for interactive information exchange on novel treatment strategies and options
- Translate the latest studies and research achievements into clinical guidance for the optimal management of people living with HIV
- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients
- Create a platform for interactive information exchange on novel treatment strategies and options
- Translate the latest studies and research achievements into clinical guidance for the optimal management of people living with HIV
Learning Objectives
After participating in the HIV Clinical Forum, participants will be able to:
- Understand the scientific rationale and clinical data supporting novel treatment strategies
- Describe the pros and cons of novel treatment strategies and drugs
- Understand how to integrate novel treatment strategies into routine patient care
- Be knowledgeable of the clinical data supporting long-acting injectable regimens
- Identify patients who might most benefit from long-acting injectable regimens
- Gain knowledge on how to optimally integrate injectable drugs into routine clinical care
- Improve their skills in defining and identifying treatment experienced people living with HIV
- Stay informed on new drug options for treatment experienced people living with HIV
- Understand how best to use new treatment options for highly treatment experienced people living with HIV
- Understand the scientific rationale and clinical data supporting novel treatment strategies
- Describe the pros and cons of novel treatment strategies and drugs
- Understand how to integrate novel treatment strategies into routine patient care
- Be knowledgeable of the clinical data supporting long-acting injectable regimens
- Identify patients who might most benefit from long-acting injectable regimens
- Gain knowledge on how to optimally integrate injectable drugs into routine clinical care
- Improve their skills in defining and identifying treatment experienced people living with HIV
- Stay informed on new drug options for treatment experienced people living with HIV
- Understand how best to use new treatment options for highly treatment experienced people living with HIV
Practical Information
We trust that the following information (in alphabetical order) will assist you in organizing your participation in the European HIV Clinical Forum 2022.
Certificate of Attendance
A certificate of attendance will be sent by e-mail shortly after the forum meeting.
Disclaimer
This forum meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of meeting, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from the meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending this forum meeting.
Language
The official language of this meeting is English.
Liability and Insurance
By registering for this forum meeting, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance if this forum is either Physical or Hybrid. Participants are advised to take out their own insurance policies.
Meeting Materials
An official program and speakers' bios will be sent by e-mail prior to the meeting.
Payment and Procedure of Online Registration
The registration fee is waived for all healthcare practitioners. You will get a confirmation of your registration within 1-5 business days. If you do not receive a confirmation, please contact Ms. Dagmar Jónasdóttir at Dagmar@amededu.com.
Photographs, Audio, and Video Recording
Photographs, as well as audio and video recordings, are not permitted at the official forum meeting sessions. Only the official medical writer, appointed by the organizer, may make recordings. All presentations will be posted on the forum website as soon as possible after the meeting is finished, provided that the speaker has given their permission to do so.
Venue
The venue for the European HIV Clinical Forum 2022 will be the Hyatt Regency Paris Étoile, located at the following address: 3 Pl. du Général Kœnig, Paris, France.
Committees
Program Director
Local Chair
The Program Chairs are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the forum meeting, identify interesting topics and candidate speakers, and review all submitted abstracts.
Support
Support
The European HIV Clinical Forum 2022 is supported by an independent educational grant from ViiV Healthcare.
ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Endorsers
The European HIV Clinical Forum 2022 is endorsed by the following societies and organizations:
Accreditation
EACCME® Accreditation
The European HIV Clinical Forum 2022, Paris, France, 07/06/2022-07/06/2022 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 5 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Previous Editions
Previous Editions
- 7th Edition - European HIV Clinical Forum, 2021, Virtual
- 6th Edition - European HIV Clinical Forum, 2020, Virtual
- 5th Edition - European HIV Clinical Forum, 2019, Switzerland
- 4th Edition - European HIV Clinical Forum, 2018, United Kingdom
- 3rd Edition - European HIV Clinical Forum, 2017, Italy
- 2nd Edition - European HIV Clinical Forum, 2016, Glasgow
Top-Rated Materials from Previous Editions
Immunology and Inflammation - Victor Appay, PhD
European HIV Clinical Forum 2021
Venue
Meeting Venue
The meeting will be held at Hyatt Regency Paris Étoile.
- Website: Hyatt Regency Paris Étoile
- Address: 3, Place du Général Kœnig, Paris, Île-de-France, France, 75017
(please click here to view the map) - Phone: +33 0 1 40 68 12 34
- E-mail: parisetoile.regency@hyatt.com
In case you have any questions or concerns regarding the venue, please feel free to contact Ms. Natalia Voronina at natalia.voronina@amededu.com.
COVID-19
Health & Safety Measures regarding COVID-19
Ensuring the health and safety of our attendees, suppliers, and staff is our absolute number one priority. In order to provide a safe conference environment, all hybrid and live events organized by Virology Education will follow the national health and safety measures of the country where the meeting is being held in. We kindly ask that all attendees carefully abide by these measures to assist us in ensuring a safe environment for all.
National Health & Safety Measures
The health and safety measures that will be taken by Virology Education during the European HIV Clinical Forum are listed on the government website of France. In addition, you can find relevant hygiene protocols on the venue website. Please read them very carefully before travelling to the conference venue.
Our staff will be available onsite to address any questions or concerns that you might have. If you have any questions in advance, please contact the Conference Secretariat at natalia.voronina@amededu.com.
Travelling to France
Virology Education strongly advises participants to check the government website of France for the latest and most accurate information about the rules regarding travel.
Please be aware of measures such as testing requirements, vaccination requirements, whether your country of origin is mentioned on the Red List, etc.
What if I get ill during the event?
Should an attendee become ill or exhibit COVID-19 symptoms at any time during the event, the attendee will safely withdraw from the event venue and immediately notify the event organizer with details of other attendees which have been in close contact at the event. By registering for the event, the attendee declares, acknowledges, and accepts that they will comply with all local government requirements should they become ill or exhibit COVID-19 symptoms during the event.
Liability Waiver
Virology Education cannot guarantee that its participants, volunteers, partners, or others in attendance will not become infected with COVID-19.
To the maximum extent permitted by law, Virology Education accepts no liability for any illness, COVID-19 related or otherwise, that may subsequently be contracted after or during the event.
All participants acknowledge and agree that they are attending the event at their own risk.
Language
Related Programs
